NEW YORK, May 18, 2015 /PRNewswire/ -- VeriTeQ Corporation (OTCBB: VTEQ) provides implantable medical device identification and radiation dose measurement technologies to the healthcare industry in the United States. It develops devices for measuring the radiation dose delivered to patients during radiation therapy treatment for cancer. The company's Q Inside Safety Technology, is a passive implantable RFID micro-transponder, and a proprietary hand-held reader and corresponding database.
VeriTeQ's Q Inside Safety Technology is a first-of-its-kind implantable RFID technology was cleared for use by the FDA in 2004 as a Class II medical device. Originally the micro-transponder was used to identify at-risk patients at the point of care. That micro-transponder for subcutaneous use in humans is no longer being sold or marketed in the United States or elsewhere. It has now evolved to help medical device manufacturers identify their products during manufacturing, supply chain, and distribution, and more importantly, to help physicians identify medical devices from within the body after they are implanted.
Analyst comments and recommendation can be viewed by using the link below. There is no cost obligation required to view this report.
Copy and paste to browser may be required.
This report may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of mentioned company to be materially different from the statements made herein.
Content is researched, written and reviewed on a best-effort basis. This report was prepared for informational purposes only. Affiliated parties involved with producing and issuing this report have not been compensated in any form by profiled company. A full disclaimer can be found by viewing the full analyst report.
This document, article or report is written and authored by a 3rd party research analyst. However, we are only human and may make mistakes. If you notice any errors or omissions, please notify us below.
BrokerBank Securities, Inc. is a member of the Financial Industry Regulatory Authority, CRD number #130116.
SOURCE BrokerBank Securities, Inc.